| Title: | Targeting cystatin F activation enhances NK cell cytotoxicity in glioblastoma models |
|---|
| Authors: | ID Senjor, Emanuela (Author)
ID Habič, Anamarija (Author)
ID Švajger, Urban (Author)
ID Mitrović, Ana (Author)
ID Proj, Matic (Author)
ID Porčnik, Andrej (Author)
ID Prestor, Borut (Author)
ID Jerala, Miha (Author)
ID Bošnjak, Matic (Author)
ID Gobec, Stanislav (Author)
ID Breznik, Barbara (Author)
ID Kos, Janko (Author)
ID Perišić, Milica (Author) |
|---|
| Files: |  URL - Source URL, visit https://doi.org/10.3389/fimmu.2025.1708281
 PDF - Presentation file, download (6,02 MB)
MD5: 890A2A7EC5AB96611751D25EAA2CE722
|
|---|
| Language: | English |
|---|
| Typology: | 1.01 - Original Scientific Article |
|---|
| Organization: |  NIB - National Institute of Biology
|
|---|
| Abstract: | Introduction: Glioblastoma (GBM) is a highly invasive brain tumor with limited treatment options and poor prognosis. Natural killer (NK) cells are key effectors of antitumor immunity, capable of eliminating cancer stem-like cells. However, GBM creates an immunosuppressive microenvironment that limits NK cell function. Here, we identify cystatin F as an immunosuppressive factor involved in regulating NK cell granule-mediated cytotoxicity. Methods: We analyzed cystatin F expression in GBM and its correlation with immune exhaustion markers. NK cell activity was compared between GBM patients and healthy donors. In vitro co-cultures of cystatin F-expressing microglial cells and glioblastoma stem-like cells were used to assess NK cell function. To block cystatin F activation from dimeric to active monomeric form, a small-molecule inhibitor of cathepsin V, the activating protease, was applied. Results: Cystatin F expression correlated with immune exhaustion and suppression markers in GBM. NK cells from patients showed reduced cytotoxicity compared to healthy donors. Co-cultures confirmed that cystatin F-expressing microglia impaired NK cell cytotoxicity, while inhibition of cathepsin V restored NK cell function in standard cytotoxicity assays, 3D spheroids, and microfluidic perfused models. Discussion: These results indicate that cystatin F mediates NK cell suppression in GBM. Targeting its activation enhances NK cell cytotoxicity, offering a potential strategy to improve NK-based immunotherapy for glioblastoma. |
|---|
| Keywords: | glioblastoma, cystatin F, 3D models |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Publication date: | 28.10.2025 |
|---|
| Year of publishing: | 2025 |
|---|
| Number of pages: | str. 1-14 |
|---|
| Numbering: | Vol. 16, [art. no.] 1708281 |
|---|
| PID: | 20.500.12556/DiRROS-24363  |
|---|
| UDC: | 577 |
|---|
| ISSN on article: | 1664-3224 |
|---|
| DOI: | 10.3389/fimmu.2025.1708281 |
|---|
| COBISS.SI-ID: | 258230275 |
|---|
| Note: | Nasl. z nasl. zaslona;
Soavtorji iz Slovenije: Anamarija Habič, Urban Švajger, Ana Mitrović, Matic Proj, Andrej Porčnik, Borut Prestor, Miha Jerala, Matic Bošnjak, Stanislav Gobec, Barbara Breznik, Janko Kos, Milica Perišić Nanut;
Opis vira z dne 21. 11. 2025;
|
|---|
| Publication date in DiRROS: | 26.11.2025 |
|---|
| Views: | 113 |
|---|
| Downloads: | 103 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
